{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:05:15Z","timestamp":1773338715577,"version":"3.50.1"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1093\/jjco\/hyn146","type":"journal-article","created":{"date-parts":[[2009,1,25]],"date-time":"2009-01-25T01:26:28Z","timestamp":1232846788000},"page":"183-185","source":"Crossref","is-referenced-by-count":24,"title":["Metastatic Adrenocortical Carcinoma Treated with Sunitinib: A Case Report"],"prefix":"10.1093","volume":"39","author":[{"given":"Jeong-Ok","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keun-Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Jong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haeryoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Mee","family":"Bang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,1,24]]},"reference":[{"key":"key\n\t\t\t\t20170502111447_HYN146C1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.cco.0000198976.43992.14","article-title":"Adrenocortical carcinoma","volume":"18","author":"Roman","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"key\n\t\t\t\t20170502111447_HYN146C2","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170502111447_HYN146C3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.2002.20.4.941","article-title":"Adrenocortical carcinoma: clinical, morphologic, and molecular characterization","volume":"20","author":"Stojadinovic","year":"2002","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170502111447_HYN146C4","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170502111447_HYN146C5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1677\/erc.1.01025","article-title":"Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial","volume":"12","author":"Berruti","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t20170502111447_HYN146C6","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1023\/A:1008377915129","article-title":"Streptozocin and o,p\u2019DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use","volume":"11","author":"Khan","year":"2000","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20170502111447_HYN146C7","first-page":"55","article-title":"Adrenocortical carcinoma","volume":"65","author":"van Ditzhuijsen","year":"2007","journal-title":"Neth J Med"},{"key":"key\n\t\t\t\t20170502111447_HYN146C8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1677\/erc.1.01124","article-title":"The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R","volume":"13","author":"Gross","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t20170502111447_HYN146C9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1530\/eje.0.1500345","article-title":"Circulating vascular endothelial growth factor and active renin concentrations and prostaglandin E2 urinary excretion in patients with adrenal tumours","volume":"150","author":"Zacharieva","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20170502111447_HYN146C10","first-page":"9","article-title":"Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours","volume":"35","author":"Kolomecki","year":"2001","journal-title":"Endocr Regul"},{"key":"key\n\t\t\t\t20170502111447_HYN146C11","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1200\/JCO.2005.03.195","article-title":"CASE 2. Response in a patient with metastatic adrenal cortical carcinoma with thalidomide","volume":"23","author":"Chacon","year":"2005","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170502111447_HYN146C12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(06)69446-4","article-title":"Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial","volume":"368","author":"Demetri","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170502111447_HYN146C13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/39\/3\/183\/14096332\/hyn146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T13:58:57Z","timestamp":1503496737000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article-lookup\/doi\/10.1093\/jjco\/hyn146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,24]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,1,24]]},"published-print":{"date-parts":[[2009,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyn146","relation":{},"ISSN":["1465-3621","0368-2811"],"issn-type":[{"value":"1465-3621","type":"electronic"},{"value":"0368-2811","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1,24]]}}}